A simple and simultaneous determination of acyclovir and ganciclovir in human plasma by high-performance liquid chromatography

Biomedical Chromatography

Volumn 17, Issue 8, 2003, Pages 500-503

  Teshima, Daisuke ^a   Otsubo, Kaori ^a   Yoshida, Tsuneko ^a   Itoh, Yoshinori ^a   Oishi, Ryozo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Antiviral agents; Nucleoside analogues of guanosine; Reversed phase chromatography; Therapeutic monitoring; UV detection

Indexed keywords

ANTIVIRAL AGENTS; BIOMOLECULES; CHROMATOGRAPHIC ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PLASMA (HUMAN); VIRUSES;

GANCICLOVIR; GUANOSINES; HUMAN PLASMAS; NUCLEOSIDE ANALOG OF GUANOSINE; NUCLEOSIDE ANALOGS; REVERSED PHASE CHROMATOGRAPHY; SIMPLE++; SIMULTANEOUS DETERMINATIONS; THERAPEUTIC MONITORING; UV DETECTION;

SIGNAL TO NOISE RATIO;

ACICLOVIR; ANTIVIRUS AGENT; GANCICLOVIR; PERCHLORIC ACID; PLASMA PROTEIN;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PRECIPITATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SIGNAL NOISE RATIO; SPECTRAL SENSITIVITY; SPECTROPHOTOMETRY; STATISTICAL PARAMETERS;

EID: 0347519169     PISSN: 02693879     EISSN: None     Source Type: Journal    
DOI: 10.1002/bmc.258     Document Type: Article

References (17)

1. Bangaru RA, Bansal YK, Rao ARM, Gandhi TP. Rapid, simple and sensitive high-performance liquid chromatographic method for detection and determination of acyclovir in human plasma and its use in bioavailability studies. Journal of Chromatography B 2000; 739: 231.
2. Boulieu R, Gallant C, Silberstein N. Determination of acyclovir in human plasma by high-performance liquid chromatography. Journal of Chromatography B 1997; 693: 233.
3. Bustamante CI and Wade JC. Herpes simplex virus infection in the immunocompromised cancer patient. Journal of Clinical Oncology 1991; 9 (10): 1903.
4. Campanero MA, Sadaba B, Garcia-Quetglas E, Azanza JR. Development and validation of a sensitive method for the determination of ganciclovir in human plasma samples by reversed-phase high-performance liquid chromatography. Journal of Chromatography B 1998; 706: 311.
5. Chu F, Mang C-H, Sung M-L, Huang B, Reeve RL, Tarnowski T. A rapid, sensitive HPLC method for the determination of ganciclovir in human plasma and serum. Journal Pharmaceutical and Biomedical Analysis 1999; 21: 657.
6. Cociglio M, Peyrière H, Hillaire-Buys D, Alric R. Application of a standardized coextractive cleanup procedure to routine high-performance liquid chromatography assays of teicoplanin and ganciclovir in plasma. Journal of Chromatography B 1998; 705: 79.
7. Crumpacker CS. Drug therapy: ganciclovir. New England Journal of Medicine 1996; 335 (10): 721.
8. Jong MD, Galasso GJ, Gazzard B, Griffiths PD, Jabs DA, Kern ER, Spector SA. Summary of the II international symposium on cytomegalovirus. Antiviral Research 1998; 39: 141.
9. Locksley RM, Flournoy N, Sullivan KM, Meyers JD. Infection with varicella-zoster virus after marrow transplantation. Journal of Infections Disease 1985; 152 (6): 1172.
10. Olsen BA. Hydrophilic interaction chromatography using amino and silica columns for the determination of polar pharmaceuticals and impurities. Journal of Chromatography A 2001; 913: 113.
11. Page T, Sherwood C, Connor JD, Tarnowski T. Simple reverse-phase high-performance liquid chromatography quantitation of ganciclovir in human serum and urine. Journal of Chromatography B 1996; 675: 342.
12. Pham-Huy C, Stathoulopoulou F, Sandouk P, Scherrmann JM, Palombo S, Girre C. Rapid determination of valaciclovir and acyclovir in human biological fluids by high-performance liquid chromatography using isocratic elution. Journal of Chromatography B 1999; 732: 47.
13. Piketty C, Bardin C, Gilquin J, Gairard A, Kazatchkine MD, Chast F. Monitoring plasma levels of ganciclovir in AIDS patients receiving oral ganciclovir as maintenance therapy for CMV retinitis. Clinical Microbiological Infection 2000; 6 (3): 117.
14. Prentice HG, Gluckman E, Powles RL, Ljungman P, Milpied NJ, Rañada JMF, Mandelli F, Kho P, Kennedy L, Bell AR. Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. Lancet 1994; 343: 749.
15. Stover BH, Bratcher DF. Varicella-zoster virus: Infection, control, and prevention. American Journal of Infection Control 1998; 26 (3): 369.
16. Tornatore KM, Garey KW, Saigal N, Reed K, Murray B, Ingalls E, DiFransesco R, Forrest A, Morse G, Venuto R. Ganciclovir pharmacokinetics and cytokine dynamics in renal transplant recipients with cytomegalovirus infection. Clinical Transplantation 2001; 15: 297.
17. Wagstaff AJ, Faulds D, Goa KL. Aciclovir: a reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1994; 47 (1): 153.